Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study
Go back to Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study| Janex International, Inc. (NASDAQ: JANX) | Delayed: 15.54 +0.88 (6.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.66 | 52 Week High | $0.01 | |||
| Open | $14.85 | 52 Week Low | $0.00 | |||
| Day High | $15.59 | P/E | N/A | |||
| Day Low | $14.64 | EPS | $0.00 | |||
| Volume | 1,037,771 | |||||

